Showing results (1161-1170 of 6,956) with videos related to
Sort By:
Pageof 696
Journal of Clinical Pharmacology|December 22, 2018
Pharmacokinetics, Pharmacodynamics, and Safety of E6011, a Novel Humanized Antifractalkine (CX3CL1) Monoclonal Antibody: A Randomized, Double-Blind, Placebo-Controlled Single-Ascending-Dose StudyHiroko Tabuchi, Toshinori Katsurabara, Masahiko Mori, et al.Journal of Clinical Pharmacology|December 27, 2018
Treatment and Prevention of CMV Disease in Transplant Recipients: Current Knowledge and Future PerspectivesAimee C Hodowanec, Andreas Pikis, Takashi E Komatsu, et al.Journal of Clinical Pharmacology|November 1, 1986
Clinical pharmacology of muscle relaxants in patients with burnsJ Martyn, D R Goldhill, N G GoudsouzianJournal of Clinical Pharmacology|June 9, 2022
The Impact of Suboptimal 25-Hydroxyvitamin D Levels and Cholecalciferol Replacement on the Pharmacokinetics of Oral Midazolam in Control Subjects and Patients With Chronic Kidney DiseaseStacey M Tuey, Linda Prebehalla, Amandla-Atilano Roque, et al.Journal of Clinical Pharmacology|June 14, 2022
Gastrointestinal Bleeding During Direct Oral Anticoagulant Therapy in Patients With Nonvalvular Atrial Fibrillation and Risk of PolypharmacyTaku Honda, Koichiro Abe, Minoru Oda, et al.Journal of Clinical Pharmacology|July 2, 2022
Using Endogenous Biomarkers to Derisk Assessment of Transporter-Mediated Drug-Drug Interactions: A Scientific PerspectiveVikram Arya, Kellie S Reynolds, Xinning YangJournal of Clinical Pharmacology|November 18, 2020
Impact of Physiologically Based Pharmacokinetics, Population Pharmacokinetics and Pharmacokinetics/Pharmacodynamics in the Development of Antibody-Drug ConjugatesChunze Li, Shang-Chiung Chen, Yuan Chen, et al.Journal of Clinical Pharmacology|November 18, 2020
Informing Development of Bispecific Antibodies Using Physiologically Based Pharmacokinetic-Pharmacodynamic Models: Current Capabilities and Future OpportunitiesJohn P Gibbs, Theresa Yuraszeck, Carla Biesdorf, et al.Journal of Clinical Pharmacology|November 18, 2020
Dose Optimization in Kidney Disease: Opportunities for PBPK Modeling and SimulationYoko Franchetti, Thomas D NolinJournal of Clinical Pharmacology|November 18, 2020
Application of PBPK Modeling and Simulation for Regulatory Decision Making and Its Impact on US Prescribing Information: An Update on the 2018-2019 Submissions to the US FDA's Office of Clinical PharmacologyXinyuan Zhang, Yuching Yang, Manuela Grimstein, et al.Pageof 696